How UHS uses availability and performance monitors to ensure Cerner is optimal for its physicians
Universal Health Services is one of the 10 largest for-profit health systems in the United...
Health News 2 me
healthnews2me.com
Tag: Clinical
North Middlesex University Hospital NHS Trust to invest $15m in clinical systems
North Middlesex University Hospital NHS Trust has announced it will invest more than $15m over the...
Nurses generally satisfied with EHRs, but key pain points persist
A new report from KLAS and the Arch Collaborative finds that nearly three times as...
University of Utah Health improves turnaround time with new imaging tech
University of Utah Health provides care for residents of Utah and six surrounding states, with...
Pfizer Initiates Phase 2b/3 Clinical Trial for PF-06651600, an Oral JAK3 Inhibitor, for the Treatment of Patients with Moderate to Severe Alopecia Areata
January 3, 2019 -- Pfizer Inc. (NYSE: PFE) announced today the initiation of a Phase...
Incyte Announces First Patient Treated in Phase 3 Clinical Trial Program for Ruxolitinib Cream in Atopic Dermatitis
WILMINGTON, Del.--(BUSINESS WIRE)--Dec. 20, 2018-- Incyte (Nasdaq:INCY) today announced that the first patient has been...
Blueprint Medicines Announces Updated Results from Ongoing EXPLORER Clinical Trial of Avapritinib Demonstrating Broad Clinical Activity and Significant Symptom Reductions in Patients with Systemic Mastocytosis
CAMBRIDGE, Mass., Dec. 2, 2018 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in...
Isofol Announces Initiation of a Pivotal Phase 3 Clinical Trial of arfolitixorin for the Treatment of Metastatic Colorectal Cancer
GOTHENBURG, Sweden, November 15, 2018 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL)...
Iterum Initiates SURE 2 and SURE 3 Phase 3 Clinical Trials of IV and Oral Sulopenem in Complicated Urinary Tract and Complicated Intra-abdominal Infections
DUBLIN, Ireland and CHICAGO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM),...
Amicus Therapeutics Announces Regulatory and Clinical Updates for AT-GAA in Pompe Disease
CRANBURY, N.J., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a global biotechnology...